Finance

Lists
Why is XGN up 3,06%?
Dive Deeper
XGN:NASDAQ
Exagen Inc
US$8,42
+3,06%
(+0,25) 1D
US$8,42
0,00% (0,00)
After hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XGN...
Open
US$8,17
High
US$8,55
Low
US$7,98
Mkt. cap
203,98 ລ້ານ
Avg. vol.
278,77 ພັນ
Volume
251,15 ພັນ
52-wk high
US$12,23
52-wk low
US$2,60
EPS
US$-0,81
Beta
2,12
Shares outstanding
24,22 ລ້ານ
No. of employees
218
Open
US$8,17
High
US$8,55
Low
US$7,98
Mkt. cap
203,98 ລ້ານ
Avg. vol.
278,77 ພັນ
Volume
251,15 ພັນ
52-wk high
US$12,23
52-wk low
US$2,60
EPS
US$-0,81
Beta
2,12
Shares outstanding
24,22 ລ້ານ
No. of employees
218
News stories
From web sources and news partners
About Exagen Inc
CEO-
Employees218
Founded2002
HeadquartersVista, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websiteexagen.com
Analyst ratings
Based on 5 analysts giving stock ratings to XGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for XGN in the last 3 months.
Highest
Current US$8,42
US$12,00 (+42,52%)
Average
US$10,20 (+21,14%)
Lowest
US$9,00 (+6,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Maintained
US$11,00
+30,6%
09/22/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$12,00
+42,5%
09/11/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
US$12,00
+42,5%
08/05/2026
Mark Massaro
BTIG
Buy
Reiterated
US$9,00
+6,9%
08/05/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
US$9,00
+6,9%
08/05/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
US$10,00
+18,8%
08/04/2026
Unknown Analyst
Roth MKM
Buy
Initiated
US$8,00
-5%
06/24/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
05/12/2026
William Bonello
Craig-Hallum
Buy
Reiterated
US$10,00
+18,8%
03/11/2026
Paul Knight
KeyBanc
Buy
Maintained
US$10,00
+18,8%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
17,24 ລ້ານ
16,63 ລ້ານ
17,31 ລ້ານ
19,94 ລ້ານ
Cost of goods sold
7,17 ລ້ານ
7,42 ລ້ານ
7,10 ລ້ານ
7,72 ລ້ານ
Cost of revenue
7,17 ລ້ານ
7,42 ລ້ານ
7,10 ລ້ານ
7,72 ລ້ານ
Research and development expenses
1,73 ລ້ານ
1,76 ລ້ານ
1,55 ລ້ານ
1,43 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,44 ລ້ານ
12,42 ລ້ານ
12,07 ລ້ານ
12,51 ລ້ານ
Operating expense
13,18 ລ້ານ
14,18 ລ້ານ
13,62 ລ້ານ
13,94 ລ້ານ
Total operating expenses
20,34 ລ້ານ
21,61 ລ້ານ
20,72 ລ້ານ
21,66 ລ້ານ
Operating income
-3,10 ລ້ານ
-4,98 ລ້ານ
-3,41 ລ້ານ
-1,72 ລ້ານ
Other non operating income
-
-
-132,00 ພັນ
153,00 ພັນ
EBT including unusual items
-7,09 ລ້ານ
-4,66 ລ້ານ
-3,93 ລ້ານ
-3,20 ລ້ານ
EBT excluding unusual items
-4,42 ລ້ານ
-6,26 ລ້ານ
-4,81 ລ້ານ
-2,77 ລ້ານ
Income tax expense
1,00 ພັນ
13,00 ພັນ
36,00 ພັນ
-
Effective tax rate
-0,01%
-0,28%
-0,92%
-
Other operating expenses
-
-
-
-
Net income
-7,09 ລ້ານ
-4,67 ລ້ານ
-3,97 ລ້ານ
-3,20 ລ້ານ
Net profit margin
-41,10%
-28,10%
-22,92%
-16,03%
Earnings per share
-0,31
-0,27
-0,20
-0,11
Interest and investment income
3,00 ພັນ
43,00 ພັນ
-
-
Interest expense
-1,32 ລ້ານ
-1,33 ລ້ານ
-1,27 ລ້ານ
-1,20 ລ້ານ
Net interest expenses
-1,32 ລ້ານ
-1,29 ລ້ານ
-1,27 ລ້ານ
-1,20 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,49 ລ້ານ
-4,38 ລ້ານ
-2,82 ລ້ານ
-1,09 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google